Our Resources | Association for Accessible Medicines

Access! 2023 + IGBA 2023 Conference - Last chance to register, join us in Orlando, FL on Feb 13-16!

Jan 26, 2023 | Erica Klinger

AAM Opposes HF17 Which Puts Generic and Biosimilars Savings At Risk for Minnesota Patients

AAM Report: Middlemen Block Patient Access to New Generics

Jan 23, 2023 | Susan Reilly

Study Finds Middlemen Increasingly Block Patient Access to New Generics

Desi, MD | Autoimmune disease

Jan 5, 2023 | Erica Klinger

Desi is Back Playing Soccer and Doing "Normal Kid" Stuff

Group of Patients

Jan 3, 2023 | Sara Skubikowski

Generics and Biosimilars Offer Savings for Patients Fighting Cancer, Heart Disease and Other Conditions

AAM - Your Generics & Biosimilars Industry

Dec 21, 2022 | Craig Burton

Ensuring Patient Access to Amoxicillin When Demand is High

Capitol Building - Washington D.C.

Dec 20, 2022 | Susan Reilly

AAM Statement on the Consolidated Appropriations Act of 2023

Dec 13, 2022 | Susan Reilly

AAM Statement on CMS's Proposed Rule Requiring Generic Drugs to be Covered on Generic Tiers

Video

Dec 2, 2022 | Erica Klinger

Back Together: GRx+Biosims 2022 Conference Recap

Video

Nov 30, 2022 | Erica Klinger

Desi is Back Playing Soccer and Doing "Normal Kid" Stuff

Video

Nov 28, 2022 | Erica Klinger

AAM's Erica Klinger speaks with Connor Nell and Brian Biehn from AmerisourceBergen #GBW2022

GRx+Biosims 2022 attendees

Nov 23, 2022 | Erica Klinger

Back Together: GRx+Biosims 2022 Conference Recap

Video

Nov 16, 2022 | Erica Klinger

Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek